JW Shinyak Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JW Shinyak Corp with three other
companies in this sector in South Korea:
Binex Company Ltd
sales of 81.36 billion Korean Won [US$72.41 million]
of which 73%
Hanall Biopharma Company Limited
(82.88 billion Korean Won [US$73.76 million]
of which 100%
was Medicinals and Bontanicals), and
Dongsung Pharmaceutical Company Limited
(79.72 billion Korean Won [US$70.95 million]
of which 89%
was Pharmaceutical Segment).
JW Shinyak Corp reported sales of 83.38 billion Korean Won (US$74.21 million)
December of 2016.
increase of 8.4%
versus 2015, when the company's sales were 76.95 billion Korean Won.
This was the fourth straight year of sales growth at JW Shinyak Corp.